Circulating PTN levels in humans have been associated with advancing age, and changes have been proposed as a potential diagnostic and prognostic tool for diseases like breast cancer, multiple sclerosis, and multiple myeloma disease status [27]. The gene discussed is PTN; the disease is AL amyloidosis.